NewAmsterdam Pharma Appoints John W. Smither to its Board of Directors
NAARDEN, The Netherlands and MIAMI, Feb. 06, 2023 (GLOBE NEWSWIRE) — NewAmsterdam Pharma Company N.V….
News
CymaBay Therapeutics to Present at the SVB Securities Global Biopharma Conference
NEWARK, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage…
Immutep Reaches Enrolment Target for INSIGHT-003 Trial in 1st Line NSCLC
Media Release 20 patients with 1st line non-small cell lung cancer (1L NSCLC) now enrolled…
Opiant Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Proposed Acquisition by Indivior PLC
SANTA MONICA, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals Inc. (NASDAQ: OPNT) announced…
ORYZON to Give Updates on Corporate Progress in February-March
BIO CEO & Investor Conference 2023 IASLC 2023 Targeted Therapies of Lung Cancer Meeting 16th…
PharmAla Named Exclusive MDMA Supplier to Revive Therapeutics
PharmAla Biotech will provide MDMA to Revive Therapeutics in their development of an MDMA Microneedle…
Vincerx Pharma to Participate at the SVB Securities Global Biopharma Conference
PALO ALTO, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical…
Revive Therapeutics Secures MDMA Supply from PharmAla Biotech for MDMA Transdermal Patch Development
TORONTO, Feb. 06, 2023 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB:…
Amarin Mails Letter to Shareholders Highlighting Sarissa’s Myths vs. The Facts
Company Files Investor Presentation and Urges Shareholders to Vote “AGAINST” Sarissa’s Proposals on the WHITE…
Oncotelic Announces Initiation of Clinical Study in Non-Small Lung Cell Cancer
AGOURA HILLS, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) — Oncotelic Therapeutics, Inc (OTCQB:OTLC) (“Oncotelic”, the…
aTyr Pharma Announces Achievement of Development Milestone by Partner Kyorin Pharmaceutical, Co., Ltd.
$10M milestone payment triggered by advancement of clinical program in Japan. Multiple centers in the…
Atreca and Xencor to Develop T Cell Engaging Bispecific Antibody Directed Against Novel Solid Tumor Target
SAN CARLOS, Calif., and MONROVIA, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) — Atreca, Inc. (Atreca)…
Kane Biotech Announces Extension of Term of Credit Facility
Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG,…
Sensei Biotherapeutics Signs Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) to Expand Development Plan for SNS-101, a Conditionally Active VISTA-blocking Antibody
BOSTON, Feb. 06, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company…
Context Therapeutics Highlights Clinical Responses from the Phase 2 OATH Clinical Trial Evaluating ONA-XR for the Treatment of Endometrial Cancer
ONA-XR initial data signals positive clinical activity and confirmed tumor shrinkage ONA-XR continues to be…
Clearside Biomedical Announces Leadership Team Update
ALPHARETTA, Ga., Feb. 06, 2023 (GLOBE NEWSWIRE) — Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing…
Arbutus to Participate in Three Upcoming Investor Conferences
WARMINSTER, Pa., Feb. 06, 2023 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage…
Inozyme Pharma to Host Virtual Investor and Analyst Event on Feb. 16, 2023
– Company to share topline data from ongoing Phase 1/2 trials of INZ-701 in ENPP1…
Fortinet Unveils New ASIC to Accelerate the Convergence of Networking and Security Across Every Network Edge
Fifth-generation security processing unit (FortiSP5) delivers unparalleled levels of power-efficient performance to open new frontiers…
SaiFlow Expands into North American Market and Releases Findings on Cybersecurity Vulnerabilities in EV Charging Software
SaiFlow offers strategies for working with OEMs, charge point operators and utilities to mitigate these…